ACE inhibitor–CCB combo benefits patients on tight BP control, with resistant hypertension
In the management of patients with high blood pressure (BP) or resistant hypertension, calcium channel blockers (CCB) confer a more favourable benefit than hydrochlorothiazide when added to an angiotensin converting enzyme (ACE) inhibitor, according to a posthoc analysis of the of the ACCOMPLISH trial.
ACE inhibitor–CCB combo benefits patients on tight BP control, with resistant hypertension
24 Dec 2020